India TV3 年
Expert panel approves Bharat Biotech's Covaxin for phase 2/3 trials on 2-18 year-olds
Bharat Biotech ... permission to conduct phase II/III clinical trials to evaluate the safety, reactogenicity and immunogenicity of Covaxin jabs in children aged 2 to 18 years.